Table 2.
Experimental runs and their observed responses.
| Run | Stabilizer Conc. (%w/v) |
Liquid Lipid Type | EE (%) (±SD) |
ɀ Average d.nm (±SD) |
PDI (±SD) |
Zeta Potential (ZP) mV (±SD) |
|---|---|---|---|---|---|---|
| 1 | 1 | oleic | 75.2 ± 0.1 | 306.6 ± 49.6 | 0.09 ± 0.10 | −10.2 ± 0.3 |
| 2 | 2 | oleic | 99.8 ± 0.3 | 401.6 ± 51.8 | 0.21 ± 0.12 | −8.8 ± 0.3 |
| 3 | 3 | oleic | 75.6 ± 0.3 | 440.2 ± 36.8 | 0.76 ± 0.06 | −8.8 ± 0.3 |
| 4 | 5 | oleic | 81.3 ± 0.4 | 357.9 ± 43.1 | 0.65 ± 0.10 | −2.4 ± 0.2 |
| 5 | 1 | Labrasol® | 46.5 ± 0.1 | 477.8 ± 50.2 | 0.11 ± 0.09 | −3.6 ± 0.1 |
| 6 | 2 | Labrasol® | 56.5 ± 0.1 | 656.7 ± 105.8 | 0.93 ± 0.06 | 0.06 ± 0.19 |
| 7 | 3 | Labrasol® | 73.9 ± 0.2 | 695.8 ± 163.5 | 0.34 ± 0.33 | −1.1 ± 0.0 |
| 8 | 5 | Labrasol® | 86.9 ± 0.7 | 1658.7 ± 325.1 | 0.56 ± 0.46 | −0.19 ± 0.07 |
| 9 | 1 | Caproyl® 90 | 31.6 ± 0.1 | 512.7 ± 56.7 | 0.14 ± 0.11 | −5.2 ± 1.2 |
| 10 | 2 | Caproyl® 90 | 25.1 ± 0.1 | 489.2 ± 66.6 | 0.10 ± 0.09 | −0.08 ± 0.05 |
| 11 | 3 | Caproyl® 90 | 50.8 ± 0.1 | 708.9 ± 90.1 | 0.25 ± 0.14 | −0.31 ± 0.03 |
| 12 | 5 | Caproyl® 90 | 79.9 ± 0.4 | 1251.3 ± 228.8 | 0.09 ± 0.01 | −0.21 ± 0.02 |
| 13 | 1 | Miglyol® 840 | 34.5 ± 0.3 | 558.5 ± 42.1 | 0.69 ± 0.28 | −5.4 ± 0.5 |
| 14 | 2 | Miglyol® 840 | 52.0 ± 0.9 | 490.1 ± 76.8 | 0.85 ± 0.13 | −0.64 ± 0.59 |
| 15 | 3 | Miglyol® 840 | 61.9 ± 0.8 | 740.2 ± 111.7 | 0.46 ± 0.45 | −0.47 ± 0.06 |
| 16 | 5 | Miglyol® 840 | 98.4 ± 0.8 | 1421.7 ± 376.2 | 1 ± 0 | −0.80 ± 0.11 |